Ian Campbell

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

Viviana Galimberti, Bernard F. Cole, Giuseppe Viale et al. · The Lancet Oncology · 2018 · 565 citations

Medicine, Oncology, Surgery +17

Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3–07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study

Boon Chua, Emma Link, Ian Kunkler et al. · The Lancet · 2022 · 107 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Impact of Zoledronic Acid in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: Z-FAST, ZO-FAST, and E-ZO-FAST.

Robert E. Coleman, N.J. Bundred, Richard de Boer et al. · Cancer Research · 2009 · 63 citations

Medicine, Oncology, Pharmacology +17

Postmastectomy Radiation Therapy in Women with T1-T2 Tumors and 1 to 3 Positive Lymph Nodes: Analysis of the Breast International Group 02-98 Trial

Youssef H. Zeidan, Joyce G. Habib, Lieveke Ameye et al. · International Journal of Radiation Oncology*Biology*Physics · 2018 · 60 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Factors Predictive of Treatment by Australian Breast Surgeons of Invasive Female Breast Cancer by Mastectomy rather than Breast Conserving Surgery

David Roder, Helen Zorbas, James Kollias et al. · Asian Pacific Journal of Cancer Prevention · 2013 · 47 citations · Full text

Medicine, Oncology, Surgery +10